The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...

As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

Unlock faster trials & better ROI in health data with STAT. Join experts on Aug 14 to build a smarter technology ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of ...

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Robert F. Kennedy Jr. just named Mark Cruz, a Klamath member, his top tribal health adviser. In a Q&A, Cruz emphasized tribal ...

Cola, how Medicaid data will be used to track immigrants, and how overdose deaths could rise with the GOP tax law.

Medicare wants to allow far more more surgeries to be done in outpatient facilities like ambulatory surgery centers.

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...